Comparison of developmental endothelial locus-1 angiogenic factor with vascular endothelial growth factor in a porcine model of cardiac ischemia

Ann Thorac Surg. 2003 Oct;76(4):1246-51. doi: 10.1016/s0003-4975(03)00721-5.

Abstract

Background: This study compared the angiogenic effects of developmental endothelial locus-1 (DEL-1), vascular endothelial growth factor (VEGF), as well as the negative control, beta-galactosidase (beta-gal), in a porcine model of cardiac ischemia.

Methods: Twenty pigs underwent left circumflex artery occlusions. After 3 weeks, the animals received myocardial injections of adenovirus expressing beta-gal (n=6), DEL-1 (n=7), or VEGF (n=7). At 7 weeks, animals were assessed for both function and coronary flow and compared with baseline measurements.

Results: Regional wall motion index and global ejection fraction showed deterioration in function in the beta-gal group and no change in the VEGF and DEL-1 groups between the treatment and harvest time points. Preload recruitable stroke work suggested functional improvement in the VEGF group (35.8 +/- 8.6 vs 56.4 +/- 17.8, p = 0.033). The increase in the DEL-1 group was not statistically significant (27.3 +/- 9.8 vs, 40.2 +/- 19.4, p = 0.067). The beta-gal group exhibited minimal change (30.7 +/- 14.8 vs 35.9 +/- 12.1, p = 0.96). Regional blood flow as assessed by fluorescent microspheres was improved under stress conditions in the VEGF group (1.00 +/- 0.15 vs 1.15 +/-0.22, p = 0.03).

Conclusions: Treatment with VEGF led to a modest improvement in regional blood flow and cardiac function in previously ischemic myocardial tissue.

Publication types

  • Comparative Study

MeSH terms

  • Adenoviridae / genetics
  • Animals
  • Carrier Proteins / pharmacology*
  • Coronary Angiography
  • Coronary Circulation / drug effects
  • Female
  • Gene Frequency
  • Myocardial Ischemia / physiopathology*
  • Swine
  • Vascular Endothelial Growth Factor A / pharmacology*
  • Ventricular Function, Left / drug effects
  • Ventricular Function, Left / physiology

Substances

  • Carrier Proteins
  • Vascular Endothelial Growth Factor A